Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Xue Chen, Qi Zhang, Youjun Luo, Caixia Gao, Xibing Zhuang, Guoxiong Xu & Tiankui Qiao. (2016) High-dose irradiation in combination with toll-like receptor 9 agonist CpG oligodeoxynucleotide 7909 downregulates PD-L1 expression via the NF-κB signaling pathway in non-small cell lung cancer cells. OncoTargets and Therapy 9, pages 6511-6518.
Read now
Read now
Articles from other publishers (5)
Johannes Routila, Karri Suvila, Reidar Grénman, Ilmo Leivo, Jukka Westermarck & Sami Ventelä. (2021) Cancer cell line microarray as a novel screening method for identification of radioresistance biomarkers in head and neck squamous cell carcinoma. BMC Cancer 21:1.
Crossref
Crossref
Asunción Espinosa-Sánchez, Elisa Suárez-Martínez, Laura Sánchez-Díaz & Amancio Carnero. (2020) Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness. Frontiers in Oncology 10.
Crossref
Crossref
Marc J. Braunstein, John Kucharczyk & Sylvia Adams. (2018) Targeting Toll-Like Receptors for Cancer Therapy. Targeted Oncology 13:5, pages 583-598.
Crossref
Crossref
Sujuan Yuan, Tiankui Qiao, Xuan Li, Xibing Zhuang, Wei Chen, Xue Chen & Qi Zhang. (2018) Toll-like receptor 9 activation by CpG oligodeoxynucleotide�7909 enhances the radiosensitivity of A549 lung cancer cells via the p53 signaling pathway. Oncology Letters.
Crossref
Crossref
Jason R. Baird, Arta M. Monjazeb, Omid Shah, Heather McGee, William J. Murphy, Marka R. Crittenden & Michael J. Gough. (2017) Stimulating Innate Immunity to Enhance Radiation Therapy–Induced Tumor Control. International Journal of Radiation Oncology*Biology*Physics 99:2, pages 362-373.
Crossref
Crossref